UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

 

Date of Report (Date of earliest event reported):

 

April 1, 2010

 


 

 

 

 

CHIMERA INVESTMENT CORPORATION

 

 


 

(Exact name of registrant as specified in its charter)


 

 

 

 

 

Maryland

 

1-33796

 

26-0630461


 


 


(State or Other Jurisdiction

 

(Commission

 

(IRS Employer

of Incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 


 

 

 

1211 Avenue of the Americas

 

 

Suite 2902

 

 

New York, New York

 

10036


 


(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (212) 696-0100

 

 

 

 

No Change

 

 


 

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 1.01. Entry into a Material Definitive Agreement

 

 

 

On April 1, 2010, Chimera Investment Corporation (the “Company”) entered into an underwriting agreement with its manager, Fixed Income Discount Advisory Company (“FIDAC”), and Credit Suisse Securities (USA) LLC (the “Underwriter”), relating to the sale of 85,000,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”), and the granting of an over-allotment option for an additional 12,750,000 shares of Common Stock to the Underwriter solely to fulfill over-allotment (the “Public Offering”). The Public Offering is expected to close on April 7, 2010.

 

 

 

The aggregate net proceeds of the Public Offering, excluding the proceeds the Company may obtain from the exercise of the over-allotment option, to the Company (after deducting estimated expenses) are estimated to be approximately $306.9 million.

Item 9.01. Financial Statements and Exhibits.

 

 

 

(a) Not applicable.

 

 

 

(b) Not applicable.

 

 

 

(c) Not applicable.

 

 

 

(d) Exhibits:


 

 

 

 

1.1

Underwriting Agreement, dated April 1, 2010, between the Company, FIDAC and Credit Suisse Securities (USA) LLC.



SIGNATURE

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Chimera Investment Corporation

 

 

 

By:

     /s/ A. Alexandra Denahan

 

 


 

 

Name: A. Alexandra Denahan

 

 

Title: Chief Financial Officer

Date: April 1, 2010